Aqr Capital Management LLC Innoviva, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 156,574 shares of INVA stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

156,574

Previous 175,309 10.69%

Holding current value

$3 Million

Previous $2.88 Million 5.08%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $305,942 - $375,449	-18,735 Reduced 10.69%	156,574 $3.02 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $6,393 - $7,281	-444 Reduced 0.25%	175,309 $2.88 Million
Q1 2024 May 15, 2024	SELL	$14.56 - $16.78 $343,572 - $395,957	-23,597 Reduced 11.84%	175,753 $2.68 Million
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $1.35 Million - $1.79 Million	-109,875 Reduced 35.53%	199,350 $3.2 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $608,863 - $683,679	-49,221 Reduced 13.73%	309,225 $4.02 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $2 Million - $2.4 Million	-175,244 Reduced 32.84%	358,446 $4.56 Million
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $1.41 Million - $1.78 Million	131,219 Added 32.6%	533,690 $6 Million
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $1.25 Million - $1.46 Million	106,260 Added 35.87%	402,471 $5.33 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $1.68 Million - $2.2 Million	144,782 Added 95.61%	296,211 $3.44 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $291,540 - $404,736	20,359 Added 15.53%	151,429 $2.24 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $13,881 - $18,265	902 Added 0.69%	131,070 $2.54 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $203,122 - $238,998	12,767 Added 10.87%	130,168 $2.25 Million
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $55,740 - $73,580	-4,268 Reduced 3.51%	117,401 $1.96 Million
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $143,800 - $175,323	-12,559 Reduced 9.36%	121,669 $1.63 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $612,535 - $712,779	-55,383 Reduced 29.21%	134,228 $1.6 Million
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $104,001 - $139,114	11,147 Added 6.25%	189,611 $2.35 Million
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $405,617 - $568,964	-39,266 Reduced 18.03%	178,464 $1.87 Million
Q2 2020 Aug 17, 2020	SELL	$11.49 - $15.26 $140,017 - $185,958	-12,186 Reduced 5.3%	217,730 $3.04 Million
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $87,425 - $164,179	-10,780 Reduced 4.48%	229,916 $2.7 Million
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $25,926 - $36,266	-2,522 Reduced 1.04%	240,696 $3.41 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $996,668 - $1.44 Million	99,171 Added 68.85%	243,218 $2.56 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $371,502 - $423,967	-28,359 Reduced 16.45%	144,047 $2.1 Million
Q1 2019 May 14, 2019	BUY	$13.69 - $20.06 $705,637 - $1.03 Million	51,544 Added 42.65%	172,406 $2.42 Million
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $1,577 - $2,063	-113 Reduced 0.09%	120,862 $2.11 Million
Q3 2018 Nov 15, 2018	SELL	$13.63 - $15.7 $1.55 Million - $1.79 Million	-113,794 Reduced 48.47%	120,975 $1.84 Million
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $1.13 Million - $1.48 Million	-84,157 Reduced 26.39%	234,769 $3.24 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $300,978 - $370,551	-21,810 Reduced 6.4%	318,926 $5.32 Million
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $729,312 - $917,081	62,175 Added 22.32%	340,736 $4.84 Million
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $3.36 Million - $3.93 Million	278,561	278,561 $3.93 Million

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Innoviva, Inc. Transaction History